Atlas Trials

Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions

Clinical trial NCT03947528 · UNKNOWN

Trial details

NCT number
NCT03947528
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2019-03-04
Primary completion
2019-05-13
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.